Pennsylvania committee hears divergent testimony on House Bill 305 to cap insulin copays at $35

The House Insurance Committee met to consider House Bill 305, which would cap patient cost sharing for a 30‑day supply of insulin at $35. Testimony on both sides highlighted the stakes for patients, clinicians and the insurance market.

Rep. Jean McNeil, the bill's prime sponsor, told the committee she has worked on insulin affordability for about eight years and introduced HB 305 to ensure “a 30 day supply of insulin at $35 for all Pennsylvanians.” She framed the proposal as a life‑saving measure to prevent rationing and avoidable complications.

Patient testimony underscored those harms. Colleen Wynne described community members who ration insulin and the personal aid she provides: “I urge this committee to pass meaningful insulin cost capping legislation. Do not let luck be the determining factor in whether a Pennsylvanian survives tonight.” Wynne told lawmakers that retail vial prices can reach hundreds of dollars and that sharing and informal aid have become a last resort when insurance and…